Your shopping cart is currently empty

HexylHIBO hydrobromide is a type I mGluR antagonist with Kb values of 140 μM and 110 μM for the mGlu1a and mGlu5a receptors, respectively. It does not inhibit mGlu2 and mGlu4a. Additionally, HexylHIBO hydrobromide reduces spontaneous excitatory postsynaptic currents (sEPSC) in rats.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | HexylHIBO hydrobromide is a type I mGluR antagonist with Kb values of 140 μM and 110 μM for the mGlu1a and mGlu5a receptors, respectively. It does not inhibit mGlu2 and mGlu4a. Additionally, HexylHIBO hydrobromide reduces spontaneous excitatory postsynaptic currents (sEPSC) in rats. |
| Targets&IC50 | mGluR1a:140 μM (Kb) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.